| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Bottom |
| Cognigen Corporation - Posters and Presentations : Cognigen Corporation : Clinical : Endocrine Disorders : Posters : Diabetes Mellitus : Population Modeling to Guide Phase 3 Dose Selection for AC2993 (Synthetic Exendin-4) | published Wed, Nov 7, 2007 - 10:31 EST |
Presented at the 2002 ASCPT Annual Meeting, Atlanta, GA
| Cognigen Corporation - Posters and Presentations : Cognigen Corporation : Clinical : Endocrine Disorders : Posters : Diabetes Mellitus : Population Modeling to Guide Phase 3 Dose Selection for AC2993 (Synthetic Exendin-4) | published Wed, Nov 7, 2007 - 10:31 EST |
| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Top |